Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avishay Sella

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Cancers|August 23, 2020
Breast-Specific Epigenetic Regulation of DeltaNp73 and Its Role in DNA-Damage-Response of <i>BRCA1</i>-Mutated Human Mammary Epithelial CellsAyelet Avraham, Susanna Feldman, Sean Soonweng Cho, et al.
Plos One|March 22, 2014
Tissue specific DNA methylation in normal human breast epithelium and in breast cancerAyelet Avraham, Sean Soonweng Cho, Ronit Uhlmann, et al.
The Israel Medical Association Journal : IMAJ|March 23, 2013
Hyperbaric oxygen therapy for hemorrhagic radiation cystitisYaniv Shilo, Shay Efrati, Zvi Simon, et al.
Clinical Genitourinary Cancer|July 29, 2014
Activity of cabazitaxel after docetaxel and abiraterone acetate therapy in patients with castration-resistant prostate cancerAvishay Sella, Tal Sella, Avivit Peer, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2017
A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinomaIgnace B Vergote, David C Smith, Raanan Berger, et al.
The Israel Medical Association Journal : IMAJ|July 26, 2014
Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factorsDana Livne-Segev, Maya Gottfried, Natalie Maimon, et al.
The Oncologist|September 14, 2012
Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogramDaniel Keizman, Maya Gottfried, Maya Ish-Shalom, et al.
Cancer Research and Treatment|March 13, 2015
Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?Daniel Keizman, Keren Rouvinov, Avishay Sella, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2012
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinomaDaniel Keizman, Maya Ish-Shalom, Roberto Pili, et al.
Clinical Genitourinary Cancer|May 24, 2016
Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell CarcinomaDaniel Keizman, Maya Ish-Shalom, Avishay Sella, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cancers|August 23, 2020
Breast-Specific Epigenetic Regulation of DeltaNp73 and Its Role in DNA-Damage-Response of <i>BRCA1</i>-Mutated Human Mammary Epithelial CellsAyelet Avraham, Susanna Feldman, Sean Soonweng Cho, et al.
Plos One|March 22, 2014
Tissue specific DNA methylation in normal human breast epithelium and in breast cancerAyelet Avraham, Sean Soonweng Cho, Ronit Uhlmann, et al.
The Israel Medical Association Journal : IMAJ|March 23, 2013
Hyperbaric oxygen therapy for hemorrhagic radiation cystitisYaniv Shilo, Shay Efrati, Zvi Simon, et al.
Clinical Genitourinary Cancer|July 29, 2014
Activity of cabazitaxel after docetaxel and abiraterone acetate therapy in patients with castration-resistant prostate cancerAvishay Sella, Tal Sella, Avivit Peer, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2017
A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinomaIgnace B Vergote, David C Smith, Raanan Berger, et al.
The Israel Medical Association Journal : IMAJ|July 26, 2014
Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factorsDana Livne-Segev, Maya Gottfried, Natalie Maimon, et al.
The Oncologist|September 14, 2012
Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogramDaniel Keizman, Maya Gottfried, Maya Ish-Shalom, et al.
Cancer Research and Treatment|March 13, 2015
Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?Daniel Keizman, Keren Rouvinov, Avishay Sella, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2012
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinomaDaniel Keizman, Maya Ish-Shalom, Roberto Pili, et al.
Clinical Genitourinary Cancer|May 24, 2016
Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell CarcinomaDaniel Keizman, Maya Ish-Shalom, Avishay Sella, et al.
Pageof 5